drug discovery

Selecia and Fragment-based drug discovery

I’ve been working with Selcia to develop their Fragment-based drug discovery efforts.

Fragment screening has recently evolved to become a widely accepted approach to lead discovery. Selcia has established a proprietary approach to detect the weak binding interactions between fragments and therapeutic targets, based on capillary electrophoresis (CE Screen). CE has been used ... as a sensitive and robust screening technology. Selcia has acquired the associated IP and has in addition developed new and proprietary methods tailored for screening fragments.

This technology offers a number of advantages over other fragment-based screening methodologies.

Drug Discovery Resources Update

I’ve updated the drug discovery resources Read More...

Updated Bioisostere

I've updated the bioisosteres section with some contributed examples.

hERG binding data

Given the issues that many drug discovery programs have had with off-target activity at the hERG channel I've started to compile a database of literature binding data Read More...

Drug Discovery Resources Update

I updated the metal chelation pages and added a page on aromatic ring bioisosteres. Read More...